Robert J. DeVita
Affiliations: | Pharmacology | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Google:
"Robert DeVita"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Kunal Kumar | post-doc | Mount Sinai School of Medicine | |
| Hailing Li | post-doc | Mount Sinai School of Medicine | |
| Hui Wang | post-doc | Mount Sinai School of Medicine | |
| Chalada Suebsuwong | post-doc | 2017- | Mount Sinai School of Medicine |
| Khoi Q. Huynh | post-doc | 2017-2018 | Mount Sinai School of Medicine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Claridge SE, Nath S, Baum A, et al. (2025) Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer. Clinical and Translational Medicine. 15: e70078 |
| Ables JL, Israel L, Wood O, et al. (2024) A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers. Journal of Psychopharmacology (Oxford, England). 2698811241273772 |
| Rosselot C, Li Y, Wang P, et al. (2024) Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system. Science Translational Medicine. 16: eadg3456 |
| Wu R, Khamrui S, Dodatko T, et al. (2024) Characterization, Structure, and Inhibition of the Human Succinyl-CoA:glutarate-CoA Transferase, a Putative Genetic Modifier of Glutaric Aciduria Type 1. Acs Chemical Biology |
| Wang P, Wood O, Choleva L, et al. (2024) Select DYRK1A Inhibitors Enhance Both Proliferation and Differentiation in Human Pancreatic Beta Cells. Biorxiv : the Preprint Server For Biology |
| Khamrui S, Dodatko T, Wu R, et al. (2024) Characterization, structure and inhibition of the human succinyl-CoA:glutarate-CoA transferase, a genetic modifier of glutaric aciduria type 1. Biorxiv : the Preprint Server For Biology |
| Leandro J, Khamrui S, Suebsuwong C, et al. (2022) Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1. Open Biology. 12: 220179 |
| Wang P, Karakose E, Choleva L, et al. (2021) Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges. Frontiers in Endocrinology. 12: 671946 |
| He Z, Chen L, Catalan-Dibene J, et al. (2021) Food colorants metabolized by commensal bacteria promote colitis in mice with dysregulated expression of interleukin-23. Cell Metabolism |
| Kumar K, Suebsuwong C, Wang P, et al. (2021) DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes. Journal of Medicinal Chemistry |